1. A.T. Shulgin and A. Shulgin, PIHKAL: A Chemical Love Story, The Transform Press, Berkeley, California, 1991.
2. R.A. Glennon, Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships. In K. Asghar and E. De Sousa (eds.), Pharmacology and Toxicology of Amphetamine and Related Designer Drugs, NIDA Research Monograph 94, 1989, Superintendent of Documents, U.S. Government Printing Office, Washington, D.C., 20402, pp. 43–67.
3. D.E. Nichols, A.J. Hoffman, R.A. Oberlender, P. Jacob III and A.T. Shulgin, Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: Representatives of a novel therapeutic class. J. Med. Chem., 29 (1986) 2009–2015.
4. R.A. Glennon, Synthesis and evaluation of amphetamine analogues. In M. Klein, F. Sapienza, H. McClain Jr. and I. Khan (eds.), Clandestinely Produced Drugs, Analogues and Precursors, United States Department of Justice, Drug Enforcement Administration, Washington, D.C., 1989, pp. 39–65.
5. P.A. Lehmann, Stimulants and hallucinogens: Structure and stereostructure-activity relationships. In M. Klein, F. Sapienza, H. McClain Jr. and I. Khan (eds.), Clandestinely Produced Drugs, Analogues and Precursors, United States Department of Justice, Drug Enforcement Administration, Washington, D.C., 1989, pp. 117–124.